ResMed Stock Target Price and Analyst Consensus
| RMD Stock | USD 177.61 3.78 2.17% |
The current analyst and expert consensus on ResMed is Buy with 5 hold recommendations. The current projected ResMed target price consensus is 184.00 with 16 analyst opinions. One of the most common ways ResMed Inc analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to ResMed vendors, executives, and/or customers. ResMed recommendation module provides expert sentiment on the projected ResMed Inc target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 167.44 | Highest Forecast 204.24 | Target Price 184 |
ResMed |
It's important to approach ResMed's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
ResMed Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ResMed target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ResMed's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 16 | Buy |
Most ResMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ResMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ResMed Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationResMed Target Price Projection
ResMed's current and average target prices are 177.61 and 184.00, respectively. The current price of ResMed is the price at which ResMed Inc is currently trading. On the other hand, ResMed's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On ResMed Target Price
ResMed Analyst Ratings
ResMed's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about ResMed stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of ResMed's financials, market performance, and future outlook by experienced professionals. ResMed's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize ResMed price targets
ResMed's stock target price is an estimate of its future price, usually made by analysts. Using ResMed's target price to determine if it is a suitable investment can be done through the following steps:- Look at ResMed's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ResMed's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional ResMed Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ResMed is a key component of ResMed valuation and have some predictive power on the future returns of a ResMed.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ResMed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 70 shares | |
 | Chemicals Invested over 40 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Adviser Favorites Invested few shares | |
Check out Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
The data published in ResMed's official financial statements usually reflect ResMed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ResMed Inc. For example, before you start analyzing numbers published by ResMed accountants, it's critical to develop an understanding of what ResMed's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of ResMed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ResMed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ResMed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ResMed Inc. Please utilize our Beneish M Score to check the likelihood of ResMed's management manipulating its earnings.